Intestinal Lymph Flow, and Lipid and Drug Transport Scale Allometrically From Pre-clinical Species to Humans
暂无分享,去创建一个
J. Windsor | C. Porter | A. Phillips | S. Charman | W. Charman | Jiwon Hong | N. Trevaskis | Sifei Han | K. L. Phang | E. Cao | Given Lee | K. Katneni | Alistair Escott
[1] A. Eichmann,et al. The Intestinal Lymphatic System: Functions and Metabolic Implications , 2018, Cellular and molecular gastroenterology and hepatology.
[2] A. Johnston,et al. Distribution of therapeutic proteins into thoracic lymph after intravenous administration is protein size‐dependent and primarily occurs within the liver and mesentery , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[3] G. Koh,et al. Organ-specific lymphatic vasculature: From development to pathophysiology , 2018, The Journal of experimental medicine.
[4] T. Petrova,et al. Intestinal lymphatic vasculature: structure, mechanisms and functions , 2017, Nature Reviews Gastroenterology &Hepatology.
[5] M. Swartz,et al. Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challenges , 2017, Advanced drug delivery reviews.
[6] C. Porter,et al. Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral Bioavailability. , 2016, Angewandte Chemie.
[7] G. Edwards,et al. Lymphatic Transport and Lymphocyte Targeting of a Triglyceride Mimetic Prodrug Is Enhanced in a Large Animal Model: Studies in Greyhound Dogs. , 2016, Molecular pharmaceutics.
[8] J. Windsor,et al. Indications, techniques, and clinical outcomes of thoracic duct interventions in patients: a forgotten literature? , 2016, The Journal of surgical research.
[9] B. Cosimelli,et al. Understanding Oxadiazolothiazinone Biological Properties: Negative Inotropic Activity versus Cytochrome P450-Mediated Metabolism. , 2016, Journal of medicinal chemistry.
[10] D. I. Givens,et al. Fatty Acid Composition , 2016 .
[11] Christopher J. H. Porter,et al. From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity , 2015, Nature Reviews Drug Discovery.
[12] O. Dirsch,et al. Monitoring of systemic and hepatic hemodynamic parameters in mice. , 2014, Journal of visualized experiments : JoVE.
[13] V. Stella,et al. Targeted delivery of a model immunomodulator to the lymphatic system: comparison of alkyl ester versus triglyceride mimetic lipid prodrug strategies. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[14] P. Tso,et al. A Mouse Model to Evaluate the Impact of Species, Sex, and Lipid Load on Lymphatic Drug Transport , 2013, Pharmaceutical Research.
[15] R. Yolken,et al. Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis , 2012, Proceedings of the National Academy of Sciences.
[16] Timothy Kassis,et al. Dual-channel in-situ optical imaging system for quantifying lipid uptake and lymphatic pump function. , 2012, Journal of biomedical optics.
[17] K. Alitalo,et al. The lymphatic vasculature in disease , 2011, Nature Medicine.
[18] J. Brandon Dixon,et al. Lymphatic lipid transport: sewer or subway? , 2010, Trends in Endocrinology & Metabolism.
[19] Christopher J. H. Porter,et al. The Mechanism of Lymphatic Access of Two Cholesteryl Ester Transfer Protein Inhibitors (CP524,515 and CP532,623) and Evaluation of Their Impact on Lymph Lipoprotein Profiles , 2010, Pharmaceutical Research.
[20] G. Edwards,et al. The Role of the Intestinal Lymphatics in the Absorption of Two Highly Lipophilic Cholesterol Ester Transfer Protein Inhibitors (CP524,515 and CP532,623) , 2010, Pharmaceutical Research.
[21] Christopher J H Porter,et al. Lymphatic Transport of Methylnortestosterone Undecanoate (MU) and the Bioavailability of Methylnortestosterone Are Highly Sensitive to the Mass of Coadministered Lipid after Oral Administration of MU , 2009, Journal of Pharmacology and Experimental Therapeutics.
[22] F. W. Wiegel,et al. Scaling aspects of lymphocyte trafficking. , 2009, Journal of theoretical biology.
[23] Anatoliy A Gashev,et al. Lymphatic Vessels: Pressure‐ and Flow‐dependent Regulatory Reactions , 2008, Annals of the New York Academy of Sciences.
[24] C. Porter,et al. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.
[25] C. Porter,et al. The Lymph Lipid Precursor Pool Is a Key Determinant of Intestinal Lymphatic Drug Transport , 2006, Journal of Pharmacology and Experimental Therapeutics.
[26] F. W. Wiegel,et al. The complexity of the Immune System: Scaling Laws , 2006 .
[27] K. Voigt,et al. Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man , 1976, Klinische Wochenschrift.
[28] Christopher J. H. Porter,et al. Intestinal Lymphatic Transport of Halofantrine Occurs After Oral Administration of a Unit-Dose Lipid-Based Formulation to Fasted Dogs , 2003, Pharmaceutical Research.
[29] Tim Morris,et al. Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.
[30] David M. Shackleford,et al. Contribution of Lymphatically Transported Testosterone Undecanoate to the Systemic Exposure of Testosterone after Oral Administration of Two Andriol Formulations in Conscious Lymph Duct-Cannulated Dogs , 2003, Journal of Pharmacology and Experimental Therapeutics.
[31] S. Lindstedt,et al. Use of allometry in predicting anatomical and physiological parameters of mammals , 2002, Laboratory animals.
[32] G. Edwards,et al. A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine. , 2001, Journal of pharmaceutical sciences.
[33] C. Porter,et al. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. , 2000, Journal of pharmaceutical sciences.
[34] R. Obach,et al. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.
[35] C. Mansbach,et al. Intracellular movement of triacylglycerols in the intestine. , 1998, Journal of lipid research.
[36] C. Porter,et al. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion. , 1996, Journal of pharmaceutical sciences.
[37] C. Porter,et al. Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion. , 1996, Journal of pharmaceutical sciences.
[38] P. Conzen,et al. The effects of sevoflurane, halothane, enflurane, and isoflurane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs. , 1992, Anesthesiology.
[39] I I Mansbach CM,et al. Portal transport of absorbed lipids in rats. , 1991, The American journal of physiology.
[40] M. Suzuki,et al. Increased lymphocyte transport by lipid absorption in rat mesenteric lymphatics. , 1987, The American journal of physiology.
[41] V. Stella,et al. Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules , 1986 .
[42] D. Capuzzi,et al. Intestinal triglycerides are derived from both endogenous and exogenous sources. , 1985, The American journal of physiology.
[43] G. McDonald,et al. Portal venous transport of long-chain fatty acids absorbed from rat intestine. , 1980, The American journal of physiology.
[44] P. Wood,et al. Composition of human chyle chylomicrons following single fat feedings. , 1969, The American journal of clinical nutrition.
[45] R. Blomstrand,et al. The fatty acid composition of human thoracic duct lymph lipids. , 1960, The Journal of clinical investigation.
[46] I. Chaikoff,et al. Intestinal lymph as pathway for transport of absorbed fatty acids of different chain lengths. , 1951, The American journal of physiology.